[go: up one dir, main page]

FI950290L - Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö - Google Patents

Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö Download PDF

Info

Publication number
FI950290L
FI950290L FI950290A FI950290A FI950290L FI 950290 L FI950290 L FI 950290L FI 950290 A FI950290 A FI 950290A FI 950290 A FI950290 A FI 950290A FI 950290 L FI950290 L FI 950290L
Authority
FI
Finland
Prior art keywords
preparation
bioactive compositions
new bioactive
new
compositions
Prior art date
Application number
FI950290A
Other languages
English (en)
Swedish (sv)
Other versions
FI950290A0 (fi
FI950290A7 (fi
Inventor
Gyoergy Hangay
Gaborne Olah
Edit Tokos
Gyoergy Vamos
Erno Mehesz
Ernone Mehesz
Original Assignee
Vepex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vepex Kft filed Critical Vepex Kft
Publication of FI950290L publication Critical patent/FI950290L/fi
Publication of FI950290A0 publication Critical patent/FI950290A0/fi
Publication of FI950290A7 publication Critical patent/FI950290A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI950290A 1992-07-22 1993-03-18 Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö FI950290A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9202398A HU212426B (en) 1992-07-22 1992-07-22 Process for producing bioactive pharmaceutical compositions
PCT/HU1993/000016 WO1994002148A1 (en) 1992-07-22 1993-03-18 Novel bioactive compositions, preparation and use thereof

Publications (3)

Publication Number Publication Date
FI950290L true FI950290L (fi) 1995-01-23
FI950290A0 FI950290A0 (fi) 1995-01-23
FI950290A7 FI950290A7 (fi) 1995-01-23

Family

ID=10982190

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950290A FI950290A7 (fi) 1992-07-22 1993-03-18 Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö

Country Status (18)

Country Link
US (1) US5622927A (fi)
EP (1) EP0651641B1 (fi)
JP (1) JPH08501533A (fi)
KR (1) KR950702421A (fi)
AT (1) ATE170752T1 (fi)
AU (1) AU688260B2 (fi)
BG (1) BG62036B1 (fi)
CA (1) CA2140630A1 (fi)
CZ (1) CZ283011B6 (fi)
DE (1) DE69320968T2 (fi)
FI (1) FI950290A7 (fi)
HU (1) HU212426B (fi)
NZ (1) NZ251424A (fi)
PL (1) PL171031B1 (fi)
RO (1) RO111735B1 (fi)
RU (1) RU2117479C1 (fi)
SK (1) SK279276B6 (fi)
WO (1) WO1994002148A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1062111C (zh) * 1995-12-06 2001-02-21 李启荣 杂交水稻制种花期花时调节剂
US5750122A (en) * 1996-01-16 1998-05-12 The Procter & Gamble Company Compositions for treating hair or skin
DE69831878D1 (de) 1997-11-24 2006-02-23 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
RU2164135C1 (ru) * 2000-04-27 2001-03-20 Рудько Адолина Петровна Глазной антисептик
US6964949B2 (en) 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
RU2176910C1 (ru) * 2000-06-26 2001-12-20 Ростовский государственный университет Антиоксидант
US7205320B2 (en) * 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
ITMI20010913A1 (it) * 2001-05-04 2002-11-04 Univ Pavia Composizioni a rilascio controllato di acido lattico a livello vaginale
US8118789B2 (en) * 2002-02-20 2012-02-21 Abbott Research Group, Inc. Deodorizer devices and systems for controlling perspiration-related body odor
US6589216B1 (en) 2002-02-20 2003-07-08 Abbott Research Group, Inc. Vaginal douches, vaginal douche applicators and methods of vaginal douching
US7270653B2 (en) * 2002-02-20 2007-09-18 Abbott Research Group Methods of treating abnormal biological conditions using metal oxides
RU2228744C2 (ru) * 2002-06-24 2004-05-20 Ростовский государственный университет Антиоксидантное средство
US20050271746A1 (en) * 2004-05-18 2005-12-08 Abbott Chun L Topical treatments for abnormal biological conditions and method of topically treating such conditions
JP4807972B2 (ja) * 2005-06-01 2011-11-02 株式会社池田模範堂 皮膚外用剤
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
EP2560669B2 (en) * 2010-04-21 2017-10-04 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
GB202018068D0 (en) * 2020-11-17 2020-12-30 Ucl Business Ltd Pharmaceutical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35991B1 (en) * 1971-01-22 1976-07-21 Comprehensive Pharmaceuticals Improvements in or relating to the treatment of diseases of the skin and mucosa
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
US4393066A (en) * 1981-06-05 1983-07-12 Garrett David M Method for treatment of herpetic lesions
HU190732B (en) * 1983-09-08 1986-10-28 Richter Gedeon Vegyeszet Process for preparing n-/1(s)-substituted-propyl/-(s)-alanyl-(s)-proline-derivatives
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4665069A (en) * 1985-04-02 1987-05-12 Barnett Rosenberg Analgesic composition and method of relieving pain
WO1988004927A1 (en) * 1986-12-31 1988-07-14 Davirand, Inc. Compositions and formulations containing folic acid, method of treating tissue with folic acid and method for preparing compositions and formulations of folic acid
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface

Also Published As

Publication number Publication date
BG62036B1 (bg) 1999-01-29
CZ15395A3 (en) 1995-09-13
EP0651641B1 (en) 1998-09-09
PL171031B1 (pl) 1997-02-28
BG99360A (bg) 1995-12-29
AU688260B2 (en) 1998-03-12
SK279276B6 (sk) 1998-09-09
DE69320968D1 (de) 1998-10-15
CZ283011B6 (cs) 1997-12-17
JPH08501533A (ja) 1996-02-20
RU2117479C1 (ru) 1998-08-20
NZ251424A (en) 1997-06-24
SK7795A3 (en) 1995-07-11
WO1994002148A1 (en) 1994-02-03
HUT64840A (en) 1994-03-28
EP0651641A1 (en) 1995-05-10
US5622927A (en) 1997-04-22
AU3903193A (en) 1994-02-14
FI950290A0 (fi) 1995-01-23
HU212426B (en) 1996-06-28
PL307256A1 (en) 1995-05-15
CA2140630A1 (en) 1994-02-03
FI950290A7 (fi) 1995-01-23
ATE170752T1 (de) 1998-09-15
KR950702421A (ko) 1995-07-29
RO111735B1 (ro) 1997-01-30
HU9202398D0 (en) 1992-10-28
DE69320968T2 (de) 1999-04-15

Similar Documents

Publication Publication Date Title
FI952179A7 (fi) Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
FI941747L (fi) Koostumuksia ja niiden käyttöjä
FI902106A0 (fi) Plastoelastisia polypropyleenikoostumuksia, niiden valmistus ja käyttö
FI935072A7 (fi) Uudet perhydroisoindolit ja niiden valmistus
FI934274A7 (fi) N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset
FI921802L (fi) Uusia bioaktiivisia pinnotteita ja niiden valmistus ja käyttö
BR9205313A (pt) Composiçáo bioativa
FI923775A7 (fi) 2-piperatsinoniyhdisteet, niiden valmistus ja käyttö
FI900696A7 (fi) Parannettuja herbisidikoostumuksia ja niiden käyttö
FI950290L (fi) Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö
FI902629A7 (fi) Aryylioksifenyylipropyyliamiineja, niiden valmistus ja käyttö
FI900461A7 (fi) Imidatsopyridatsiinit, niiden valmistus ja käyttö
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FI943645L (fi) Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI970997A7 (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI934325A7 (fi) Hyönteismyrkkykoostumus ja hyönteismyrkky-yksiköitä
FI934680A7 (fi) Aryylimorfoliini, valmistus ja käyttö
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
ITMI912261A0 (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
FI944040A7 (fi) Laktolijohdannaiset, niiden valmistus ja käyttö
FI945439L (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset
FI964899A7 (fi) Uusia taksoideja, niiden valmistus ja niitä sisältäviä koostumuksia
FI941517A7 (fi) Bentsonaftyridiinin-1,8 johdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
FI914525A7 (fi) Yhdiste, käyttö ja valmistus
FI894323L (fi) Antimikrobiaalinen ainekoostumus, menetelmä ja käyttö

Legal Events

Date Code Title Description
FD Application lapsed